Skip to main content
. 2014 Jul 30;18:262. doi: 10.11604/pamj.2014.18.262.4804

Table 1.

Summary of the 20 HIV/AIDS-research questions with the highest average scores based on the pre-workshop questionnaire (lines highlighted in grey: more than 10% of the respondents were undecided to give high or low priority).

Research areas Topics Undecided (%) Average
General Implementation research 6,9 1,07
General HIV prevention, general 0,0 1,24
HIV andtuberculosis Studies on provision of screening of TB patients for HIV 0,0 1,21
HIV andtuberculosis Identification of best strategies for the co-management of TB and HIV care 0,0 1,29
HIV Care Paediatriccoverage 3,7 1,14
HIV Care Identification of socio-economic, behavioural, cultural, structural and other factors that have an impact on ART access and can be influenced by the programme 3,7 1,17
HIV epidemiology Proportion of individuals becoming newly infected (incidence) 3,6 1,11
HIV prevention Evaluation of combination of prevention approaches 3,4 1,24
Monitoring, datausage Comprehensive inventory of publicly available data on HIV/AIDS 7,1 1,24
Monitoring, datausage Studies on utilization of data 0,0 1,28
PMTCT Evaluation of combination of prevention approaches 0,0 1,28
PMTCT Early infant diagnosis – what is the proportion of mothers receiving test results 7.1 1.32
HIV care Screening for cervical intraepithelial lesions (PAP) 25,0 1,14
HIV care Contributionof private sector 14,8 1,28
HIV epidemiology Numbers of individuals requiring ART 10,7 1,29
HIV support Have workplace programs affected stigma and discrimination at the workplace 29,6 1,03
HIV support To what extent does access to treatment promote HIV disclosure? 10,7 1,24
PMTCT Identification of best strategies for provision and monitoring of CD4 testing and treatment for pregnant and breastfeeding women 10,7 1,18
PMTCT Factors influencing the retention of care in the first 12 months of life 14,3 1,29
PMTCT To what extent are recommendations regarding feeding options are understood by the service providers at different levels in the health delivery system 32,1 1,29